Definitive Contract 75N93021C00056
Award Date
8/1/21
Potential Completion Date
7/31/23
Potential Value
$600K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Silver Lake Research Corporation
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irwindale, CA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $600,000 firm fixed price contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Silver Lake Research Corporation, doing business as Silver Lake Research Corp., for EAP-derived monoclonal antibodies for phenotyping guinea pig immune cells under Phase I of the Small Business Innovation Research (SBIR) program for fiscal year 2020. As a total small business set-aside, the contract supports Silver Lake's research and development...
The Department of Homeland Security Science and Technology Directorate awarded a firm-fixed-price contract valued at $1,656,989.53 to Silver Lake Research Corporation, a for-profit organization and manufacturer of goods, for the rapid detection of high-priority foreign animal pathogens using enzyme-linked immunosorbent assay (ELISA)-derived hyperspecific monoclonal antibodies. This contract, which does not have a set-aside designation, is for the development of rapid testing innovations,...
This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Silver Lake Research Corporation, a small business manufacturer of rapid testing innovations. The $466,200 Firm Fixed Price contract is for the development of "HYPERSPECIFIC MONOCLONAL ANTIBODIES AND LATERAL FLOW ASSAYS" and does not have a set-aside designation. Silver Lake Research Corporation is also the recipient of prime federal contracts and grants from agencies such as the National...
This is a Cost Plus Fixed Fee contract awarded by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate to Silver Lake Research Corporation, a small business, for research and development services related to the generation, validation, and characterization of new monoclonal antibodies reactive with a group of toxins. The contract has a ceiling value of $1,167,200.00 and an ultimate completion date of December 31, 2019. This award does not have a set-aside designation....
Sri International has been awarded a $14.5 million cost-plus-fixed-fee delivery order by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health within the Department of Health and Human Services (HHS). The delivery order is for Task Order B-1 under an existing contract vehicle to support animal model development and efficacy testing of candidate monoclonal antibodies (mMABs) against infectious disease targets over a five-year period of...
This is a $5,545.00 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Lakepharma, Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract is for custom antibody and protein purification services to be performed in Belmont, CA. Lakepharma, Inc. is a contract development and manufacturing organization (CDMO) that has previously...
This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $600,000 to Qoolabs Inc. for monoclonal antibodies research aligned with SBIR Topic 107. The solicitation sought Small Business Innovation Research (SBIR) proposals across technical topics within NIH Institutes and CDC Centers to develop medical technologies, diagnostics, vaccines, cell therapies and...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Lakepharma, Inc., a minority-owned, for-profit biopharmaceutical contract development and manufacturing organization (CDMO). The $20,000 contract is for the "heavy and light humanization of 1B3 MAB", which involves antibody humanization services to support NIAID's medical research and healthcare mission. The...
This is a federal contract awarded by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate to Silver Lake Research Corporation, a for-profit small business manufacturer. The $999,169.20 cost-plus-fixed-fee contract is for research and development services to create and validate small molecule select agent toxin detection assays. The contract has an ultimate completion date of July 21, 2020 and was awarded on December 31, 2015. This contract is not set aside for any...
This $600,000 definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of San Diego, California. The contract is for SBIR Topic 107 to develop affinity reagents for the immune system of the golden hamster, in alignment with the original solicitation seeking Small Business Innovation Research proposals across technical topics within NIH and CDC. Work will be performed in San Diego through September 2024 under...